Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to […]
More Stories
Global Trade Could Accelerate the Green Economy, but Countries Need Stronger Cooperation
Solar energy is becoming an increasingly important part of global trade, investment and the transition towards a low-carbon economy. Image: TheUltimateGrass...
AI’s Growing Energy Appetite Is Creating a New Global Infrastructure Challenge
Data centres are becoming essential infrastructure for artificial intelligence, cloud computing and the global digital economy. Photo: Carl Lender, via...
How AI Can Help Businesses Reduce Website Development Costs
In 2023, McKinsey set up a lab and timed more than 40 of its own software developers on routine tasks,...
iPhone Overheating? Common Causes and Fixes
Apple designs its phones to work in different environments, including high air pressure, humidity, and hot and cold weather. When...
Global Trade’s New Geography: Developing Economies Face a Choice
By Looking Times | 14 November 2026 Photo: Igor Ovsyannykov, “Shipping containers in a port” (Port of Barcelona), via Wikimedia...
The AI Investment Boom: Can Record Spending Deliver Real Productivity?
Global Trade in 2026: AI Investment Is Rewriting the Map of World Commerce By Looking Times | November 13, 2026...
